Fabricator: Zyvex Pharmaceuticals
Unit: x1 100 tabs
Strength: 25 mg/tab
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Ibutamoren is the odd one out on this shelf, and the label matters: it is not a steroid and not a SARM. It is a ghrelin receptor agonist, which means it mimics the hunger hormone to make the pituitary release more growth hormone, and IGF-1 rises behind it. Testosterone, LH and the androgen receptor are not involved at any point.
That is why it can be run for months, stacked with suppressive compounds, and stopped without a recovery protocol. Zyvex supplies it as a tablet in a foil blister, batch coded on the box.
MK 677 binds the ghrelin receptor in the hypothalamus and pituitary, amplifying the natural pulses of growth hormone rather than replacing them. Those pulses are largest during deep sleep, which is why the first thing most users notice is sleep quality rather than anything visible in a mirror.
The half-life is roughly four to six hours, but the downstream effect on GH and IGF-1 lasts most of a day, so once-daily dosing is enough. It does not shut down endogenous GH production the way exogenous growth hormone does, and it does not suppress the androgen axis at all.
The active ingredient is MK 677 at the per-tablet strength printed on the Zyvex blister. The tablet base uses standard binders, filler, disintegrant and lubricant, and the complete excipient panel is on the box. There is no growth hormone, no testosterone and no stimulant in the formulation.
Take it at night, roughly half an hour before bed, so the amplified pulse lands near the natural sleep peak. Food does not matter much for absorption, but taking it on a full stomach can make the hunger effect more noticeable rather than less.
The first week can leave you lethargic, and that usually settles. Water retention in the hands and feet is dose related and eases when the dose comes down. Fasting glucose is the marker worth checking if you plan to run it for months, because growth hormone raises insulin resistance.
Reported ranges, not a prescription:
Water retention and tingling hands are the GH-side markers to expect, both dose dependent. Lethargy in the first week is common. Appetite can rise sharply, which is either the point of the run or the reason it ends.
Blood sugar is the one that matters over months: growth hormone impairs insulin sensitivity, so anyone with pre-diabetes or a family history of type 2 should be cautious. Prolactin rises in a minority of users, and vivid dreams are reported often enough to count as normal.
Baseline fasting glucose and IGF-1, then again at week eight. If glucose drifts upward, reduce the dose or stop. There is no HPTA suppression to recover from, so no PCT is needed, but that does not make the compound risk-free.
Not for under-21s, anyone with diabetes or pre-diabetes without medical supervision, or anyone pregnant or nursing. Store at room temperature, dry and out of light, in the sealed blister. Sold for research use, and the laboratory testing for this range is pending rather than published.
Please log in to write Ibutamoren (MK 677) review.
It will not. The ghrelin receptor has nothing to do with the androgen axis, so there is no suppression and no recovery protocol at the end of a run.
Ghrelin is the hunger signal, and ibutamoren mimics it. The appetite increase is the mechanism working, not a side effect to fight.
Half an hour before bed. The largest growth hormone pulses come during deep sleep, and the timing puts the amplified release where the body already expects one.
It is the main marker over months: growth hormone reduces insulin sensitivity, so fasting glucose at baseline and again at week eight is the check that matters.
No, though most shops file it with them. It is a growth hormone secretagogue, and the mechanism, the side effects and the recovery profile are all different.